Last reviewed · How we verify

NCT04789395

Evaluation of Post-covid 19 Patients Who Receive Ozonetheraphy With Thorax CT

Status unknown Last updated 9 March 2021
What this trial tests

trial in Ozone Therapy for Covid 19 Pneumonia Patients in 25 participants. Status unknown.

Timeline
2 September 2020
Primary endpoint
20 September 2021
20 December 2021

Quick facts

Lead sponsorGaziosmanpasa Research and Education Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment25
Start date2 September 2020
Primary completion20 September 2021
Estimated completion20 December 2021
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

Adults 18 to 80, any sex, with Ozone Therapy for Covid 19 Pneumonia Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is known that enhances wound healing by oxidative stress and supports immune system besides it is cheap and has not any side effects. Aim of the study is to prevent pulmonary fibrosis by using ozone therapy as a supportive therapy on the patients who have pneumonia and ground glass opacity on thorax CT both in ICU and wards. Patients will follow for a year.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Insights on the mechanisms of action of ozone in the medical therapy against COVID-19.
    Chirumbolo S, Valdenassi L, Simonetti V, Bertossi D, et al · · 2021 · cited 29× · PMID 34020394 · DOI 10.1016/j.intimp.2021.107777
  2. COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases.
    Fukihara J, Kondoh Y. · · 2023 · cited 15× · PMID 37429073 · DOI 10.1016/j.resinv.2023.05.007
  3. Clinical effectiveness of medical ozone therapy in COVID-19: the evidence and gaps map.
    Serra MEG, Baeza-Noci J, Abdala CVM, Luvisotto MM, et al · · 2023 · cited 9× · PMID 37077114 · DOI 10.4103/2045-9912.372819

Verify or expand the search:

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04789395.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing